bcg-medac
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - bcg vakcína - 59 - immunopraeparata
navirel
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - vinorelbín - 44 - cytostatica
pamifos
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - kyselina pamidrónová - 44 - cytostatica
epimedac 2 mg/ml injekčný roztok
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - epirubicín - 44 - cytostatica
metoject 50 mg/ml injekčný roztok
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - metotrexát - 44 - cytostatica
doxorubicin medac 2 mg/ml infúzny roztok
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - doxorubicín - 44 - cytostatica
bleomedac 15000 iu
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - bleomycín - 44 - cytostatica
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastické činidlá - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
trecondi
medac gesellschaft für klinische spezialpräparate mbh - treosulfan - transplantácia hematopoetických kmeňových buniek - antineoplastické činidlá - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.
mitomycin medac 40 mg prášok a rozpúšťadlo na intravezikálny roztok
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - mitomycín - 44 - cytostatica